Key points are not available for this paper at this time.
Inhibitors of proximal and terminal complement cascades can often control red-cell hemolysis associated with paroxysmal nocturnal hemoglobinuria, but some patients have breakthrough hemolysis.
Notaro et al. (Wed,) studied this question.